MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications

Research output: Contribution to journalShort survey

79 Scopus citations

Abstract

MicroRNAs (miRNAs) are a group of small non-coding RNA molecules of 17-25 nucleotides (nt) in length, predicted to control the activity of about 30% of all protein-coding genes in mammals. Altered expressions of miRNAs are reported in various cancers and may associate with cancer pathogenesis, apoptosis, and cell growth, thereby functioning as either tumor suppressors or oncogenes. Recent reports showed that deregulation of miRNA contribute to tumor development and progression and hence, have diagnostic and prognostic value in several human malignancies. This review discusses the current status of miRNA in pancreatic cancer development, progression, diagnosis, and therapy.

Original languageEnglish (US)
Pages (from-to)8-16
Number of pages9
JournalCancer Letters
Volume292
Issue number1
DOIs
StatePublished - Jun 1 2010

    Fingerprint

Keywords

  • Diagnosis and therapy
  • MicroRNA
  • Pancreatic cancer

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this